Harvard Bioscience, Inc. (NASDAQ:HBIO)

CAPS Rating: 4 out of 5

A developer, manufacturer and marketer of a range of specialized products, primarily apparatus and scientific instruments, used to improve life science research at pharmaceutical & biotechnology companies, universities & government laboratories worldwide.


Player Avatar joelochi (< 20) Submitted: 6/9/2008 5:04:13 PM : Outperform Start Price: $3.78 HBIO Score: -22.69

Just look at the charts.

Featured Broker Partners